Evidence map›Paper›PMID 40901326›Full record

ReviewWorld journal of clinical oncology2025

Current advances in neuroendocrine neoplasms of the colon and rectum.

Yun-Bin Ma, Zhi-Jie Wang

Abstract readReview
In one paragraph

Review in World journal of clinical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yun-Bin MaThe First Surgical Department, Hebei Medical University Yiling Hospital, Shijiazhuang 050000, Hebei Province, China.
Zhi-Jie WangKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Gastrointestinal Cancer Center, Peking University Cancer Hospital & Institute, Beijing 100142, China. 1459046932@qq.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Compared with colorectal adenocarcinoma, neuroendocrine neoplasms (NENs), which affect the colon and rectum, are uncommon tumor conditions that have received relatively limited attention in basic research. Furthermore, the scarcity of these NENs has hindered extensive clinical investigations, thereby leading to a dearth of robust evidence for guiding clinical practice and impeding the establishment of standardized approaches for diagnosis and treatment. However, with the increasing awareness of population screening, as well as the increasing popularity of colonoscopy screening programs, the incidence of colorectal NENs has gradually increased. Moreover, some high-grade NENs are highly malignant and invasive, thereby leading to poor treatment outcomes and prognoses. These challenges have elicited increased attention from clinical physicians, thus prompting researchers to explore relevant studies using limited specimens and clinical data. This scenario has resulted in preliminary findings that provide evidence for addressing diagnostic and therapeutic challenges associated with NENs of the colon and rectum. In this article, we review recent literature reports and summarize the advances regarding the diagnosis and treatment of colorectal NENs.

Indexed as

ColonDiagnosisNeuroendocrine neoplasmRectumResearch progressTreatment

Identifiers

PMID40901326
PMCPMC12400215

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.